|
ISSCR Newsletter
Volume 1, No. 3
November 2002
Editor's Note
Suzanne Kadereit, Ph.D.
Case Western Reserve University
Cleveland, OH
The ISSCR Newsletter is published quarterly for members and friends
of the International Society for Stem Cell Research.
Your
feedback and submissions to this newsletter are encouraged. Send
information, updates, calendar listings, citations and other material
for consideration to the editor at sxk79@po.cwru.edu
or to ISSCR Headquarters at psullivan@isscr.org.
Lastly,
I encourage you to forward this newsletter to individuals who might
be interested in joining our new stem cell research society.
In This Issue:
President's Message
Dear
Members:
The
ISSCR continues to grow in its membership and one of its missions
is to provide interconnectivity to researchers, the lay public,
government and reporters.
Perhaps
the best mechanism for our Society to establish this communication
is through our website. We are in the process of securing funding
to allow us to alter our website so that it is a better interactive
source of information. Below I have listed our goals with respect
to the website.
I am
looking for feedback and also interesting ideas that we can list
on the website.
We
plan to utilize state of the art graphics with language that can
be understood by the lay audience as well as experienced investigators.
The
improvement in the website will be predominantly based on two aspects:
1)
improvement in design; and 2) the hiring of dedicated individuals
who are focused on the website.
In
particular, one individual will work on the daily upkeep and the
creation of new links. The other person will focus on scientific
aspects regarding stem cell biology, community and interactions
among investigators in the field, members of the ISSCR, as well
as interactions with other foundations.
The
following items will be included on the website:
1)
Definitions. Even in its perfunctory form, we have found that
many reporters and government officials are utilizing the website
for definitions of terminology. We plan to update these definitions.
Such definitions will remain simple and straightforward, and in
the future could be illustrated. For instance, the process of nuclear
cloning will be described for senior investigators and for the lay
public.
2)
Ethical Discussions. The Board is lucky to have Laurie Zoloth
as a member. She has been extremely influential in the bioethics
of stem cells and has authored several publications and books on
this matter. We plan to develop ethical statements that will be
posted on our website. This can then be utilized by government officials,
as well as reporters, for a better understanding and promotion of
discussion among the various groups developing opinions on stem
cell derivation and use. We also plan to develop position statements
for the ISSCR. For instance, Rudy Janesch has developed a statement
on cloning that is currently being reviewed by our Policy Committee.
This will be posted on our website.
3)
Literature search. It is very important that the stem cell field
maintain up-to-date resources. For instance, I was recently asked
by the Australian government for a complete compilation of stem
cell literature regarding the use of human embryonic stem cells.
It was possible to obtain the National Academy of Sciences reports
and a link from our website, but it would also be important to proactively
generate literature searches that could be used for a variety of
purposes.
4)
Bringing membership together. Our website will link stem cell
researchers. Since our membership encompasses much of the community
and in particular, our Board and committee members form many of
the leaders, we think we are in a unique position to bring stem
cell researchers together through our website. Our website will
list contact information for members and searchable areas of expertise
(using key words). Over the next couple of years, we will develop
user groups among stem cell researchers, lay people and government
officials. This will allow links so that information about stem
cell biology can be available to the community and potential collaborations
can be fostered.
5)
Job searching. It is clear that a number of academic institutes
and industry are now generating stem cell biology jobs, including
professorships and junior faculty. It is critical to hire high quality
investigators and this can be advertised through our website.
6)
Grant opportunities for stem cell researchers. It is clear that
there are many mechanisms to fund stem cell researchers. Many institutions,
associations, and foundations want a better view of the investigators
and topics relevant to their interests. This aspect of the website
will be invaluable for furthering the field as we attempt to bring
stem cells to the bedside. This may be an excellent resource for
initiating collaborations.
7)
Creating new alliances. Several academic websites have links
to stem cell biology. Interconnectivity is very important and the
website. The connector of these sites will be facilitated with a
dedicated person working on the science of the field.
8)
Meetings. There are numerous stem cell meetings and a focused
website delineating these times and places will be extremely useful
for the community.
9)
Storage of Newsletters. We plan to create a library of our Newsletters,
so that new members can have up-to-date information.
10)
Listing of available Human ES and EG lines. As many of you know,
there are currently only a few lines available. The website can
list these with information such as karyotype analysis, etc.
As
you can see, this is an all encompassing plan. Our hope is that
the hiring of a full time science editor will facilitate many of
these goals and will establish more connections within the stem
cell field.
Sincerely,
Leonard
I. Zon, M.D.
ISSCR
President
Back
to Top
News
Human stem cell bank:
Financed by a grant from the MRC (U.K.), the first bank for worldwide
collection and distribution of stem cell lines derived from human
embryos, fetal and adult tissues should be opening within a year.
Availability
of NIH-approved human ES cell lines:
Although
a long list of human embryonic stem cell lines has been approved
by the NIH for use in federally funded US labs, actual availability
seems to have been scarce up to now. The NIH awarded several infrastructure
grants to facilitate growing and distribution of the approved cell
lines. Hopefully the supply bottleneck will soon be passed.
If
you have cell lines included in the NIH list in your laboratory
and need additional support for distribution to the research community,
please contact:
Dr. John W. Thomas
Division of Blood Diseases and Resources / NHLBI / NIH
Phone: 301-435-0050
E-mail: ThomasJ@nhlbi.nih.gov
Human stem cell legislation:
Australia:
Legislation supposed to be passed in August, banning human cloning,
but allowing use and derivation of human ES cells, has been postponed
to December 2003.
Canada:
Somatic nuclear transfer prohibited, but derivation of new ES cell
lines allowed.
European
Union:
The debate still goes on whether to allow derivation of new ES cell
lines under the 6th Framework Program. There will probably be a
moratorium on derivation of new cell lines until December 2003 for
funding under this Framework Program.
Austria,
Italy, Ireland and Spain:
Work on human ES cell lines and embryos is banned, Spain is considering
new legislation.
Belgium:
Research on embryos is allowed, reproductive cloning is prohibited.
Germany:
Import of cell lines existing before January 2002 is allowed if
approved by a national review board.
France:
New legislation is on hold, due to government change. Interim regulation
allowing import of existing cell lines also on hold.
Netherlands:
Research is allowed on human embryos when there is no reasonable
alternative, reproductive cloning is banned.
Sweden:
Derivation of new embryonic stem cell lines allowed, reproductive
cloning prohibited.
United
Kingdom:
Stem cell lines can be derived from human embryos, nuclear transfer
to create cell lines also allowed.
India:
No specific laws governing embryo research, derivation and use of
human ES cells are subject of approval by institution's internal
review boards. New legislation pending that would prohibit export
of any part of an embryo.
Israel:
Research on embryos allowed, similar to Sweden.
Japan:
With approval of local and national ethics review board, derivation
and use of human ES cell lines permitted, human cloning banned.
Korea:
Legislation pending allowing work on surplus embryos, but banning
of human reproductive cloning. Decisions on allowing the use of
somatic nuclear transfer to create stem cells will be left to a
bioethics committee.
Singapore:
Currently, ES cell research and therapeutic cloning permitted. Pending
legislation banning human reproductive cloning.
United
States:
For federally funded researchers only use of cell lines posted on
the NIH web site is permitted. California passed state law (September
22) explicitly allowing researchers to derive ES cell lines and
to clone embryos to study and treat diseases (regulated by institutional
review boards), thus opening private and state funding. Temporary
ban on reproductive cloning has been made permanent.
Back to Top
Forum
Announcement
by Una Chen, PhD, Head of the Stem Cell Therapy Program at the University
of Giessen (Germany):
Dear
Colleagues,
We
are planning a publication on the origins of stem cell research
and on the people that were involved in it.
Much
attention has been drawn recently to stem cells. It has become
a frequent topic of public debate and dinner table conversation.
Most
people, however, know nothing about the pioneers who have spent
many silent years of hard work creating this field during its dark
stone age. I have
been discussing this question with several of the leaders in the
field and
would like to invite you to contribute to this article so that your
experiences can be shared by readers who are interested in learning
more
about stem cell research and its researchers.
You
are more than welcome to spread the word to people who may not
have received this message so that their voices can be heard and
documented and their discoveries discussed.
We aim to focus our attention to totipotent stem cells and tissue-specific
stem cells of all species but are quite open to suggestions.
Looking forward to hearing from you,
Una
Chen, Ph.D.-U.C.Berkeley
Head of Stem Cell Therapy Program
Med. Microbiology Institute
University of Giessen, Friedrichstrasse 24 D-35392 Giessen, Germany
Tel & FAX: +49-641-99-47459 (Office)
E-mail addresses: Una.Chen@gmx.de
or
Una.Chen@mikrobio.med.uni-giessen.de
http://www.med.uni-giessen.de/biochem/
Back to Top
Funding
UNITED
KINGDOM:
Alzheimer's
Research Trust:
Dementia Research
Deadline: November 8, 2002
http://www.alzheimers-research.org.uk/scientists
http://www.qrd.ion.ucl.ac.uk
Research
into Aging:
Call for proposals for research carried out in U.K., exception:
cancer research
Deadline: several, depending on program
http://www.ageing.org
Address: Research into Ageing, PO Box 32833, London N1 9ZQ
Tel: 020- 7843-1572
GERMANY:
Humboldt
Research Fellowship Program:
All research plans, conducted in German institutions.
Deadline: Applications are accepted at any time
http://www.humboldt-foundation.de
avh@bellatlantic.net
UNITED
STATES:
NIGMS
NIGMS has announced two initiatives to encourage and facilitate
basic research involving human embryonic stem cells. The first announcement
is for administrative supplements to NIGMS grantees. The receipt
date for requests for administrative supplements is May 5, 2003.
The second announcement is an RFA for Exploratory Center Grants
for Human Embryonic Stem Cell Research.
The
receipt date for this RFA is March 13, 2003. Details of these initiatives
can be found at http://www.nigms.nih.gov/funding/stemcells.html.
In addition, this site contains links to the report of the NIGMS
Workshop on the Basic Biology of Mammalian Stem Cells and to other
resources for human embryonic stem cell research.
Questions about the Notice for Administrative Supplements can be
addressed to a grantee's NIGMS program director. Questions about
the RFA for Exploratory Center Grants may be addressed to:
Marion M. Zatz, Ph.D.
Zatzm@NIGMS.NIH.Gov
301-594-0943 Phone
301-480-2228 FAX
State
of New Jersey Commission on Spinal Cord Research
Basic or clinical research on spinal cord injury and disease ($200,000/year,
1-2 years).
Deadline: January 3, 2003
http://www.state.nj.us/health/spinalcord/
Tel: 609-292-4055
njscr@doh.state.nj.us
McKnight
Endowment Fund for Neuroscience:
Scholar Awards:
Deadline: January 2, 2003
Technological Innovation Awards:
Deadline (Letter of Intent): December 1, 2002
Brain Disorders Awards:
Deadline (Letter of Intent): May, 2003.
http://www.mcknight.org/neuroscience
Back to Top
Stem Cell Meetings Calendar
2002
October
15-19
American Society of Human Genetics
Baltimore, MD
www.faseb.org/genetics/ashg/ashgmenu
November
18-20
12th Takeda Science Foundation Symposium on Bioscience
"Stem Cells and Organogenesis"
Registration deadline: October 11, 2002
International Conference Center Kobe, Hyogo, Japan
takedasci@congre.co.jp
http://www.congre.co.jp/takedasci/
December 6-10
44th American Society of Hematology (ASH) Annual Meeting
Convention Center
Philadelphia, Pennsylvania
http://www.hematology.org/meeting/
2003
June
8-11
International Society for Stem Cell Research
First Annual Scientific Meeting & Exhibition
Washington, DC
For more information, see the ISSCR
meetings page
January
30-February 3
American Society for Blood and Marrow Transplantation
Keystone, CO
www.asbmt
February
13-18
American Association for the Advancement of Science
Denver, Colorado
www.aaas.org
March
13-14
VIth International Meeting on In Utero Stem Cell Transplantation
and Gene Therapy
Lyon, France
http://www.fondation-merieux.org
June
4-8
American Society of Gene Therapy
Washington, DC
www.asgt.org
June
13-18
52nd Annual Montagna Symposium on the Biology of the Skin
"Stem Cells of Epithelia"
Snowmass, CO
http://www.montagnasymposium.org/
July
5-9
International Society for Experimental Hematology
Palais des Congres Paris, France
www.iseh.org
July
30-August 2
Society for Developmental Biology
Boston, MA
www.sdb.bio.purdue.edu
Keystone
Symposia of potential interest:
http://www.keystonesymposia.org
January
21-26
Toward Understanding Islet Biology (J1)
Keystone, CO
February
11-16
Optical Imaging: Applications to Biology and Medicine (C2)
Taos, NM
Session on optical imaging in stem cells on Thursday 13th.
March
29-April 3
From Stem Cells to Therapy (E3)
Steamboat Springs, CO
Send
meetings to be listed in the calendar to ISSCR headquarters:
isscr@isscr.org
Back to Top
Industrial Meetings
2003
January 15-16
Stem Cells & Cloning: Development and Opportunities
Asia/Pacific conference to promote cooperation, increase investments
and awareness in the stem cells industry.
Singapore
www.ibc-asia.com/stemcells.htm
Back to Top
Resources
Reports
and Discussion Papers by the Nuffield Council on Bioethics, London,
U.K.:
http://www.nuffieldbioethics.org
"The Nuffield Council on Bioethics is an independent body established
by the Trustees of the Nuffield Foundation in 1991 to consider the
ethical issues arising from developments in medicine and biology.
The Council is funded jointly by the Nuffield Foundation, The Wellcome
Trust and the Medical Research Council."
Reports
and Discussion papers among others, on:
Stem Cell Therapy: ethical issues 2000
Animal-to-human transplants: the ethics of xenotransplantation 1996
Human tissue: ethical and legal issues 1995
Copies
in CD-ROM form of reports and discussion papers can also be requested
at bioethics@nuffieldfoundation.org,
or downloaded from their website.
Back to Top
Reviews
July
Issue of Journal of Pathology, vol 197, with reviews on prostatic,
neural, lung epithelial, pancreatic, hepatic, gastrointestinal,
epidermal, cardiac, muscle, hematopoietic, and embryonic stem cells.
Burdon
T, Smith A, Savatier P (2002)."Signalling, cell cycle and pluripotency
in embryonic stem cells."Trends Cell Biol 12:432.
Bradley
JA, Bolton EM, Pedersen RA (2002). "Stem cell medicine encounters
the immune system." Nat Rev Immunol. 2:859.
Daley
G (2002)."Prospects for stem cell therapeutics: myths and medicines."
Curr Opin Genet Dev 12:607.
Eiges
R, Benvenisty N (2002)."A molecular view on pluripotent stem
cells." FEBS Lett 529:135.
Frisen
J (2002)."Stem cell plasticity?" Neuron 35:415.
Noel
D, Djouad F, Jorgense C (2002). "Regenerative medicine through
mesenchymal stem cells for bone and cartilage repair." Curr
Opin Investig Drugs 3:1000.
Presnell
S, Petersen B, Heidaran M (2002)."Stem cells in adult tissues."
Semin Cell Dev Biol 13:369.
Tisdale
JF, Dunbar CE (2002)."Plasticity and hematopoiesis: Circe's
transforming potion?" Curr Opin Hematol 9:268.
Weissman
IL (2002). "The road ended up at stem cells." Immunol
Rev. 185:159.
Wilmut
I, Beaujean N, De Sousa PA, Dinnyes A, King TJ, Paterson LA, Wells
DN, Young LE (2002)."Somatic cell nuclear transfer." Nature
419:583.
Back to Top
Methods Papers
Asano
T, Hanazono Y, Ueda Y, Muramatsu S, Kume A, Suemori H, Suzuki Y,
Kondo Y, Harii K, Hasegawa M, Nakatsuji N, Ozawa K (2002)."Highly
efficient gene transfer into primate embryonic stem cells with a
simian lentivirus vector." Mol Ther 6:162.
Falk
A, Holmstrom N, Carlen M, Cassidy R, Lundberg C, Frisen J (2002)."Gene
delivery to adult neural stem cells." Exp Cell Res 279:34.
Fijnvandraat
AC, De Boer PA, Deprez RH, Moorman AF (2002)."Non-radioactive
in situ detection of mRNA in ES cell-derived cardiomyocytes and
in the developing heart." Microsc Res Tech 58:387.
Levsky
JM, Shenoy SM, Pezo RC, Singer RH. (2002). "Single-cell gene
expression profiling." Science, 297:836.
Murphy
CL, Polak JM (2002)."Differentiating Embryonic Stem Cells:
GAPDH, But Neither HPRT Nor beta-Tubulin Is Suitable as an Internal
Standard for Measuring RNA Levels." Tissue Eng 8:551.
Nagano
M, Watson DJ, Ryu BY, Wolfe JH, Brinster RL (2002)." Lentiviral
vector transduction of male germ line stem cells in mice."
FEBS Lett 524:111.
Pedersen
RA (2002)."Feeding hungry stem cells." Nat Biotechnol
20:882-3.
Rathjen J, Rathjen P (2002)."Recipes for cooking with stem
cells." Trends Cell Biol 12:447.
Back to Top
Articles
Castro,
RF, Jackson KA, Goodell MA, Robertson CS, Liu H, Shine HD (2002)."
Failure of bone marrow cells to transdifferentiate into neural cells
in vivo." Science 297:1299.
Drukker
M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J,
Reubinoff B, Mandelboim O, Benvenisty N (2002)."Characterization
of the expression of MHC proteins in human embryonic stem cells."
Proc Natl Acad Sci U S A 99:9864.
Hackney
JA, Charbord P, Brunk BP, Stoeckert CJ, Lemischka IR, Moore KA (2002)."A
molecular profile of a hematopoietic stem cell niche." Proc
Natl Acad Sci U S A 99:13061.
Hanna
LA, Foreman RK, Tarasenko IA, Kessler DS, Labosky PA (2002)."Requirement
for Foxd3 in maintaining pluripotent cells of the early mouse embryo."
Genes Dev 20:2650.
Heyworth
C, Pearson S, May G, Enver T (2002)."Transcription factor-mediated
lineage switching reveals plasticity in primary committed progenitor
cells." EMBO J. 21:3770.
Humpherys
D, Eggan K, Akutsu H, Friedman A, Hochedlinger K, Yanagimachi R,
Lander ES, Golub TR, Jaenisch R (2002)."Abnormal gene expression
in cloned mice derived from embryonic stem cell and cumulus cell
nuclei." Proc Natl Acad Sci U S A 99:12889.
Ivanova
NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR (2002).
A stem cell molecular signature. Science, 298:601.
Jirmanova
L, Afanassieff M, Gobert-Gosse S, Markossian S, Savatier P (2002)."
Differential contributions of ERK and PI3-kinase to the regulation
of cyclin D1 expression and to the control of the G1/S transition
in mouse embryonic stem cells."
Oncogene 21:5515.
Kim
JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky
N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R.
(2002) "Dopamine neurons derived from embryonic stem cells
function in an animal model of Parkinson's disease." Nature,
418:50.
Ramalho-Santos
M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA (2002). "Stemness":
transcriptional profiling of embryonic and adult stem cells."
Science 298:597.
Schmidt
M, Zickler P, Hoffmann G, Haas S, Wissler M, Muessig A, Tisdale
JF, Kuramoto K, Andrews RG, Wu T, Kiem HP, Dunbar CE, von Kalle
C (2002)."Polyclonal long-term repopulating stem cell clones
in a primate model." Blood. 100:2737.
Tsai
EJ, Malech HL, Kirby MR, Hsu AP, Seidel NE, Porada CD, Zanjani ED,
Bodine DM, Puck JM (2002)."Retroviral transduction of IL2RG
into CD34(+) cells from X-linked severe combined immunodeficiency
patients permits human T- and B-cell development in sheep chimeras."
Blood100:72.
Wagers
AJ, Sherwood RI, Christensen JL, Weissman IL (2002)."Little
evidence for developmental plasticity of adult hematopoietic stem
cells." Science 297:2256.
Xu
C, Police S, Rao N, Carpenter MK (2002). Characterization and enrichment
of cardiomyocytes derived from human embryonic stem cells."Circ
Res 91:501.
Back to Top
©
2002 All rights reserved. International Society for Stem Cell Research
Return to Newsletters
Page
|